| Literature DB >> 35124598 |
Xingang Wang1, Cuiling Shao1, Wensheng Liu1, Hu Liang1, Na Li2.
Abstract
BACKGROUND: HER2 gene expression is one of the main reference indicators for breast cancer detection and treatment, and it is also an important target for tumor targeted therapy drug selection. Therefore, the correct detection and evaluation of HER2 gene expression has important value for clinical treatment of breast cancer.Entities:
Keywords: Breast cancer; HER2; classification; deep neural network; residual network
Mesh:
Year: 2022 PMID: 35124598 PMCID: PMC9028740 DOI: 10.3233/THC-228020
Source DB: PubMed Journal: Technol Health Care ISSN: 0928-7329 Impact factor: 1.205
Figure 1.Network structure.
Figure 2.Two residual units.
Figure 3.Training data.
Figure 4.Testing data.
Figure 5.Original-picture and adjustment-picture.
Figure 6.Changes in accuracy and loss.
Figure 7.The output of the network. The first column shows the category of the corresponding HER2 image presented in the second column (a), the output of the first block is shown in the third column (b), the output of the fourth block is shown in the forth column (c).
Accuracy comparison
| Approach | HER2 grading | Accuracy | Comprehensive accuracy |
|---|---|---|---|
| HER2-ResNet | 0 | 0.94 | 0.93 |
| 1 | 0.93 | ||
| 2 | 0.90 | ||
| 3 | 0.95 | ||
| SVM | 0 | 0.91 | 0.90 |
| 1 | 0.88 | ||
| 2 | 0.89 | ||
| 3 | 0.93 | ||
| AlexNet | 0 | 0.89 | 0.89 |
| 1 | 0.92 | ||
| 2 | 0.82 | ||
| 3 | 0.93 | ||
| VGG16 | 0 | 0.82 | 0.75 |
| 1 | 0.73 | ||
| 2 | 0.69 | ||
| 3 | 0.76 |
Figure 8.Comparison with different evaluation indicators.